Clinical trials in neurosurgical oncology

Area of Science:

• Neuro-oncology
• Neurosurgery
• Clinical Trials

Background:

• Diffuse infiltrating gliomas, particularly glioblastoma, present significant clinical challenges with poor prognoses despite standard multimodal therapy.
• Current survival rates for glioblastoma patients are less than two years, underscoring the need for therapeutic advancements.

Purpose of the Study:

• To review clinical trials in neuro-oncology from a neurosurgical perspective.
• To discuss the evolving and future roles of neurosurgeons in improving glioma treatment strategies.

Main Methods:

• Review of existing literature on neuro-oncology clinical trials.
• Analysis of the neurosurgical contribution to these trials.
• Discussion of potential future neurosurgical involvement in glioma research.

Main Results:

• Advances in standard and novel therapies for gliomas are emerging from clinical trial data.
• Neurosurgeons have been integral to past and ongoing clinical studies.
• Future research necessitates continued neurosurgical participation for therapeutic progress.

Conclusions:

• Neurosurgical expertise is crucial for the successful design and execution of clinical trials in glioma treatment.
• Continued neurosurgical involvement is essential for translating research findings into improved patient outcomes for brain tumor patients.